ÂÜÀòÂÒÂ×

Marisol Quintero has a wealth of experience in the field of research and innovation. Marisol began their career as a Research Fellow at University College London in 2002. In 2007, they became a Visiting Scientist at the Albert Einstein College of Medicine in New York, USA. From 2011 to 2013, they served as the Director of Innovation at CNIO, where they designed initiatives to enhance innovation within CNIO's Research Programmes. In 2011, they also became the Technology Director at Life Length. In 2015, they became a Socio at nCapital. Finally, in 2013, they became the CEO and Chief Executive Officer at Highlight Therapeutics SL, where they are currently responsible for unlocking the full potential of immuno-oncology.

Marisol Quintero attended IE Business School from 2010 to 2011, where they obtained an ExMBA. Marisol then attended UCL from 2002 to 2007, where they obtained a PhD in Pharmacology. Marisol also attended Université Paul Sabatier Toulouse III, but no degree was obtained.